Thanks stingman, appreciate you sharing the email and for Dr. Chan to take the time to respond. This reinforces what my impressions were reviewing their history and limited information on their web site. It also reinforced what did seem to be an overreach into an area outside of the area for which they received received 510k clearance for which is AKI, pulmonary edema and congestive heart failure targeting organ preservation in the solid organ transplant market.
As a side note, their recent hire for their board of directors has spent the majority of his career in management consulting and he will be overseeing their business development.
News 
Market Data 
Discover 
AI
